{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial Comparing Polyethylene Glycol-Coated Patch Versus Axillary Drainage in Breast Cancer Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Women aged \u226518 years with breast cancer scheduled for axillary lymph node dissection were randomly assigned (1:1)"
      },
      "Participants": {
        "score": 2,
        "evidence": "Women aged \u226518 years with breast cancer scheduled for axillary lymph node dissection"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned (1:1) to receive either a polyethylene glycol-coated patch or axillary drainage"
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to compare clinical outcomes and direct costs between polyethylene glycol-coated patch and axillary drainage"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcomes were the need for an emergency department visit and the incidence of seroma, measured over the postoperative period"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applied"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 227 patients were randomised between July 2019 and July 2022, with 115 in the patch group and 112 in the drainage group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on all participants using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The incidence of emergency department visits was significantly higher in the drainage group (33.0%) compared to the patch group (7.0%), with an incidence rate difference of 26.1% (95% CI 14.5 to 37.7; p < 0.0001)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Conversely, the seroma rate was higher in the patch group (49.6%) than in the drainage group (26.8%)"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04487561"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}